Chronic cough, defined as a cough lasting more than eight weeks, is a common and disruptive condition in clinical practice. Despite its prevalence, the diagnosis and treatment of chronic cough can be challenging due to its multifactorial nature, and the often complex interplay of underlying causes.
A systematic and comprehensive approach to diagnosis is imperative. History taking should focus on identifying common causes such as gastroesophageal reflux disease (GERD), upper airway cough syndrome (UACS), and non-asthmatic eosinophilic bronchitis (NAEB). A thorough physical examination, coupled with targeted investigations such as chest X-rays, spirometry, and bronchoprovocation tests, can aid in the identification of less common etiologies.
Empirical therapy based on the most likely diagnosis can be an effective initial approach. For instance, proton pump inhibitors for suspected GERD, or inhaled corticosteroids for NAEB. However, this approach requires careful patient follow-up to assess response and adjust treatment as necessary.
Emerging diagnostic tools, such as bronchial thermoplasty and impulse oscillometry, hold promise for the future. These tools can provide more precise information about airway inflammation and reactivity, potentially leading to more targeted treatments.
Ultimately, treatment should be individualized, addressing the underlying causes and taking into account patient preferences. This may involve pharmacological treatments, lifestyle modifications, or a combination of both. Refractory cases may benefit from multidisciplinary input, including pulmonology, gastroenterology, and otolaryngology expertise.
Chronic cough is a complex condition that requires a comprehensive diagnostic and therapeutic approach. By staying abreast of emerging diagnostic tools and maintaining a patient-centered focus, physicians can effectively manage this common, yet often challenging, condition.
1.
High Rate of Surgical Success in Complex NSCLC With Neoadjuvant Chemoimmunotherapy
2.
Papillary thyroid cancer: New markers offer hope for tailored treatment
3.
What Comes After Cancer?
4.
FDA Expands Durvalumab Label to Operable Lung Cancer
5.
In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.
1.
Finding Support: Connecting with the Vitiligo Community
2.
Essential Updates in Hematology in Daily Practice
3.
Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers
4.
Living Better With Advanced Cancer Through Supportive Care
5.
Understanding Epoetin and Its Role in Treating Chronic Kidney Disease
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
2.
Updates on Standard V/S High Risk Myeloma Treatment
3.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
4.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
5.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation